The Scientist - Home

Three life scientists among winners of Germany's biggest research award for 2003.

Conference on modeling the neuron demonstrates multiple levels of difficulty.

mouse hybrid plan faces patent challenge from activist Rifkin.

UK's MRC launches database of potential endocrine disrupter chemicals

Workshop seeks to set US global warming research agenda

US pressuring UN inspectors to abduct Iraqi researchers if necessary to gain information

Photo: Barry Palevitz HELP OR HINDRANCE? Ephedra-containing products like those pictured above are coming under increased scrutiny. You've probably seen the ads in the supermarket checkout aisle, or on radio and TV. "I lost 63 pounds with Hydroxycut," screams the headline in Cosmopolitan, above pictures of a woman going from corpulent to bathing-beauty trim in 19 weeks. "Diet Fuel changes the shape of your life," claims another ad, this time sporting an ab-flashing model in boxing gloves

Photo: Courtesy of King Pharmaceuticals OLD DRUG, NEW USES: Ace inhibitor ALTACE Clinical trials are under way in the United States to test new uses for angiotensin I-converting enzyme (ACE) inhibitors, as lab researchers around the world continue to compile evidence of further possibilities for the antihypertensive drugs. Meanwhile, a paper to be published this month presents a detailed theory that ACE functions at the start of a signaling pathway common to major diseases that are other

Photo: Courtesy of NASA ON THE HORIZON: New technologies will protect the health of astronauts on long space flights. Researchers at the National Space Biomedical Research Institute (NSBRI) are developing technologies to identify and monitor anticipated and unanticipated microorganisms in space--technologies, they suggest, that could also help to more efficiently diagnose medical conditions down here on Earth, as well as help detect biological hazards in this post-Sept. 11 world.1-3 Geo

File photo It is a sobering time for US stem cell researchers. Just days after a national election set the stage for the possible criminalization of embryonic stem cell research, a popular television program portrayed such cells incubating in patients in coma, ready to be used to treat a wealthy man's Parkinson disease. A video presented at the American Society for Human Genetics annual meeting in Baltimore a month earlier, however, told a very different story--this one real. The video showed

Founding father of organ transplantation dies, aged 81.

Australian Senate passes stem cell legislation and bans human cloning.